Skip to main content
SpringerLink
Log in

Tea Consumption and Risk of Type 2 Diabetes: A Meta-Analysis of Cohort Studies

  • Original Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

ABSTRACT

BACKGROUND

Tea consumption has been extensively studied in relation to various diseases, several epidemiologic studies have been performed to investigate the association of tea consumption with type 2 diabetes; however, the results of these studies were not entirely consistent.

OBJECTIVE

To conduct a meta-analysis of studies that assessed the association of tea consumption and the risk of type 2 diabetes.

RESEARCH DESIGN AND METHODS

We performed a systematic literature search through November 2008 in PUBMED, MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews. The search was limited to English-language studies. Studies were excluded if they were type 1 diabetes, animal studies. Nine cohort studies were identified by two authors, and summary relative risks (RRs) were calculated using a random-effects model.

RESULTS

We identified nine cohort studies, including 324,141 participants and 11,400 incident cases of type 2 diabetes with follow-up ranging from 5 to 18 years. The summary adjusted RR did not show that tea consumption was associated with a reduced type 2 diabetes risk (RR, 0.96; 95% confidence interval (CI), 0.92–1.01). Evidence from the results of our stratified analyses revealed that tea consumption ≥4 cups per day (RR, 0.8; 95% CI, 0.7–0.93) might play a role in the prevention of type 2 diabetes. However, no statistically significant association was observed for sex and the follow-up durations stratified between tea consumption and type 2 diabetes.

CONCLUSIONS

This meta-analysis indicates that tea consumption ≥4 cups per day may lower the risk of type 2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414–31.

    Article  PubMed  CAS  Google Scholar 

  2. Zimmet P. The burden of type 2 diabetes: are we doing enough. Diabetes Metab. 2003; 29: 6S9–18.

    Article  PubMed  CAS  Google Scholar 

  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–53.

    Article  PubMed  Google Scholar 

  4. Hu FB, Manson JE, Stampfer MJ. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001; 345: 790–7.

    Article  PubMed  CAS  Google Scholar 

  5. Robertson R, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys. 2007; 48: 139–46.

    Article  PubMed  CAS  Google Scholar 

  6. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006; 60: 308–14.

    Article  PubMed  CAS  Google Scholar 

  7. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004; 24: 816–23.

    Article  PubMed  CAS  Google Scholar 

  8. Dona M, Dell’Aica I, Calabrese F, et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol. 2003; 170: 4335–41.

    PubMed  CAS  Google Scholar 

  9. Osada K, Takahashi M, Hoshina S, Nakamura M, Nakamura S, Sugano M. Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol Part C Toxicol Pharmacol. 2001; 128: 153–64.

    Article  CAS  Google Scholar 

  10. Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem. 2003; 14: 326–32.

    Article  PubMed  CAS  Google Scholar 

  11. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr. 2002; 21: 1–13.

    PubMed  CAS  Google Scholar 

  12. Cheng TO. All teas are not created equal the Chinese green tea and cardiovascular health. Int J Cardiol. 2006; 108: 301–8.

    Article  PubMed  Google Scholar 

  13. Blumberg J. Introduction to the proceedings of the third international scientific symposium on tea and human health: role of flavonoids in the diet. J Nutr. 2003; 133: 3244S–3246S.

    PubMed  CAS  Google Scholar 

  14. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992; 21: 334–50.

    Article  PubMed  CAS  Google Scholar 

  15. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997; 37: 693–704.

    Article  PubMed  CAS  Google Scholar 

  16. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 2001; 154: 495–503.

    Article  PubMed  CAS  Google Scholar 

  17. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006; 27: 1301–9.

    Article  PubMed  CAS  Google Scholar 

  18. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors. 2000; 13: 49–54.

    Article  PubMed  CAS  Google Scholar 

  19. Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol. 2002; 83: 109–16.

    Article  PubMed  CAS  Google Scholar 

  20. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem. 2002; 277: 34933–40.

    Article  PubMed  CAS  Google Scholar 

  21. Anderson RA, Polansky MM. Tea enhances insulin activity. J Agric Food Chem. 2002; 50: 7182–6.

    Article  PubMed  CAS  Google Scholar 

  22. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr. 2008; 87: 778–84.

    PubMed  CAS  Google Scholar 

  23. Wolfram S, Raederstorff D, Preller M. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006; 136: 2512–8.

    PubMed  CAS  Google Scholar 

  24. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacology. 2004; 4: 18.

    Article  PubMed  CAS  Google Scholar 

  25. Polychronopoulos E, Zeimbekis A, Kastorini CM, Papairakleous N, Vlachou I, Bountziouka V, Panagiotakos DB. Effects of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr. 2008; 47: 10–6.

    Article  PubMed  Google Scholar 

  26. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006; 29: 398–403.

    Article  PubMed  Google Scholar 

  27. Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004; 140: 1–8.

    PubMed  Google Scholar 

  28. Greenberg JA, Axen KV, Schnoll R, Boozer CN. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes. 2005; 29: 1121–9.

    Article  CAS  Google Scholar 

  29. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr. 2005; 24: 376–84.

    PubMed  CAS  Google Scholar 

  30. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond). 2006; 30: 1742–9.

    Article  CAS  Google Scholar 

  31. Hamer M, Witte DR, Mosdøl A, Marmot MG, Brunner EJ. Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: The Whitehall II study. Br J Nutr. 2008; 4: 1–8.

    Google Scholar 

  32. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006;144:554–62.

  33. Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med. 2006; 166: 1311–6.

    Article  PubMed  Google Scholar 

  34. Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008; 88: 979–85.

    PubMed  CAS  Google Scholar 

  35. Yamaji T, Mizoue T, Tabata S, et al. Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia. 2004; 47: 2145–51.

    Article  PubMed  CAS  Google Scholar 

  36. MacKenzie T, Comi R, Sluss P, et al. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism. 2007; 56: 1694–8.

    Article  PubMed  CAS  Google Scholar 

  37. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol. 2005; 51: 335–42.

    PubMed  CAS  Google Scholar 

  38. Hosoda K, Wang MF, Liao ML, et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care. 2003; 26: 1714–8.

    Article  PubMed  CAS  Google Scholar 

  39. Ryu OH, Lee J, Lee KW, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract. 2006; 71: 356–8.

    Article  PubMed  CAS  Google Scholar 

  40. Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism. 2007; 56: 1340–4.

    Article  PubMed  CAS  Google Scholar 

  41. Nettleton JA, Harnack LJ, Scrafford CG, Mink PJ, Barraj LM, Jacobs DR Jr. Dietary flavonoids and flavonoid-rich foods are not associated with risk of type 2 diabetes in postmenopausal women. J Nutr. 2006; 136: 3039–45.

    PubMed  CAS  Google Scholar 

  42. Hodge AM, English DR, O’Dea K, Giles GG. Dietary patterns and diabetes incidence in the Melbourne Collaborative Cohort Study. Am J Epidemiol. 2007; 165: 603–10.

    Article  PubMed  Google Scholar 

  43. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000; 283: 2008–12.

    Article  PubMed  CAS  Google Scholar 

  44. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007; 298: 2654–64.

    Article  PubMed  CAS  Google Scholar 

  45. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177–88.

    Article  PubMed  CAS  Google Scholar 

  46. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539–58.

    Article  PubMed  Google Scholar 

  47. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629–34.

    PubMed  CAS  Google Scholar 

  48. Babu PV, Sabitha KE, Shyamaladevi CS. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem Biol Interact. 2006; 162: 114–20.

    Article  PubMed  CAS  Google Scholar 

  49. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV in a fructose-fed rat model. Eur J Nutr. 2004; 43: 116–24.

    Article  PubMed  CAS  Google Scholar 

  50. Wu LY, Juan CC, Ho LT, Hsu YP, Hwang LS. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem. 2004; 52: 643–8.

    Article  PubMed  CAS  Google Scholar 

  51. Islam MS, Choi H. Green tea, anti-diabetic or diabetogenic: a dose response study. BioFactors. 2007; 29: 45–53.

    Article  PubMed  CAS  Google Scholar 

  52. Chen R. Green tea, coffee, and diabetes. Ann Intern Med. 2006; 145: 633.

    PubMed  Google Scholar 

  53. Chen R, Wei L, Hu Z, Qin X, Copeland JR, Hemingway H. Depression in older people in rural China. Arch Intern Med. 2005; 165: 2019–25.

    Article  PubMed  Google Scholar 

  54. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006; 49: 837–45.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (No 30671004), “973 Project” (2006CB503902), and the Natural Science Foundation of Jiangsu Province (No BK2006006).

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Drum Tower Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu Province, China

    Yali Jing MD, Guanjun Han MD & Dalong Zhu MD, PhD

  2. Department of Endocrinology, Affiliated Drum Tower Hospital, Medical College of Nanjing University, Nanjing, Jiangsu Province, China

    Yun Hu MD, Yan Bi MD, PhD & Lirong Li MD, PhD

Authors
  1. Yali Jing MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guanjun Han MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun Hu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Bi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lirong Li MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dalong Zhu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dalong Zhu MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jing, Y., Han, G., Hu, Y. et al. Tea Consumption and Risk of Type 2 Diabetes: A Meta-Analysis of Cohort Studies. J GEN INTERN MED 24, 557–562 (2009). https://doi.org/10.1007/s11606-009-0929-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-009-0929-5

KEY WORDS

Search

Navigation